Filing Details
- Accession Number:
- 0000912282-25-000718
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-26 09:07:55
- Reporting Period:
- 2025-06-25
- Filing Date:
- 2025-06-26
- Accepted Time:
- 2025-06-26 09:07:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1509261 | Rezolute Inc. | RZLT | Pharmaceutical Preparations (2834) | 273440894 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1829608 | Kenneth Brian Roberts | C/O Rezolute, Inc. 275 Shoreline Drive, Suite 500 Redwood City CA 94065 | Chief Medical Officer | No | No | No | No |
Transaction Summary
Purchased: | 2,500 shares | Avg. Price: $4.38 | Total Value: $10,939.00 |
Number of Shares After Transactions: | 15,500 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2025-06-25 | 2,500 | $4.38 | 15,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 157,352 | Direct | |
Common Shares | 1,376 | Indirect | Held by minor child |
Footnotes
- The purchaes price reported above is a weight average price. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.38, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.